NCT07349589尚未招募1 期
A Randomized, Open-label, Single-dose, Parallel-design, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 入组人数
- 48
研究概览
简要总结
This study aimed to evaluate the safety and pharmacokinetic characteristics of DW5524 in healthy adult volunteers.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy adult volunteers aged 19 years or older at the time of screening
- •Individuals weighing 50.0 kg or more and having a body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening
排除标准
- •Those with a current or past medical history of clinically significant liver, kidney, nervous, mental, respiratory, endocrine, blood disease, tumor, genitourinary, cardiovascular, digestive, or musculoskeletal diseases.
研究者
相似试验
招募中
1 期
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting ConditionsNCT07260851Daewoong Pharmaceutical Co. LTD.40
招募中
1 期
Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.NCT07267221Daewoong Pharmaceutical Co. LTD.36
已完成
1 期
Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult VolunteersNCT07319559Daewon Pharmaceutical Co., Ltd.55
招募中
1 期
Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fasting StateNCT07297940Dong-A ST Co., Ltd.40
已完成
1 期
Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed StateNCT07342062Dong-A ST Co., Ltd.36